Lex Fridman Podcast cover image

#249 – Albert Bourla: Pfizer CEO

Lex Fridman Podcast

00:00

Advancements in COVID Treatment: Paxlovid vs Ivermectin

This chapter explores the development and emergency use of Pfizer's antiviral treatment, Paxlovid, aimed at reducing COVID-related hospitalizations. It also critically examines the controversial discussions surrounding ivermectin and emphasizes the importance of evidence-based medicine amidst ongoing debates about treatment efficacy.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app